Literature DB >> 26507261

Circulating mitochondrial biomarkers for drug-induced liver injury.

Qiang Shi1, Xi Yang1, William B Mattes1, Donna L Mendrick2, Alison H Harrill3, Richard D Beger1.   

Abstract

Liver mitochondria affected by drugs can be released into circulation and serve as biomarkers for drug-induced liver injury (DILI). The tissue specificity of ALT was improved by differentiating cytosolic ALT1 and mitochondrial ALT2 isoforms released in circulation. Prior to ALT elevation, mitochondrial cytochrome c, OCT, GLDH, CPS1 and DNA were increased in circulation following DILI. The baseline expression of mt-Nd6 was predictive of individual DILI susceptibility in animals. As mitochondrial DILI biomarkers appeared to be drug or species dependent, they might have value in clinical scenarios when culprit drugs are established, but may not be ideal tools to assess DILI potentials of new drugs.

Entities:  

Keywords:  acetaminophen; biomarker; drug-induced liver injury; hepatotoxicity; mitochondrion

Mesh:

Substances:

Year:  2015        PMID: 26507261     DOI: 10.2217/bmm.15.59

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  7 in total

1.  Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Kristopher D Rawls; Shanea K Estes; Tracy P O'Brien; Richard L Printz; Jason A Papin; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-08       Impact factor: 4.219

Review 2.  The role of mitochondria in rheumatic diseases.

Authors:  Yann L C Becker; Bhargavi Duvvuri; Paul R Fortin; Christian Lood; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2022-09-29       Impact factor: 32.286

Review 3.  Histopathological Analysis of Rat Hepatotoxicity Based on Macrophage Functions: in Particular, an Analysis for Thioacetamide-induced Hepatic Lesions.

Authors:  Jyoji Yamate; Takeshi Izawa; Mitsuru Kuwamura
Journal:  Food Saf (Tokyo)       Date:  2016-09-17

4.  Liver Effects of Clinical Drugs Differentiated in Human Liver Slices.

Authors:  Alison E M Vickers; Anatoly V Ulyanov; Robyn L Fisher
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

5.  Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria.

Authors:  Jun Zhang; Alec Salminen; Xi Yang; Yong Luo; Qiangen Wu; Matthew White; James Greenhaw; Lijun Ren; Matthew Bryant; William Salminen; Thomas Papoian; William Mattes; Qiang Shi
Journal:  Arch Toxicol       Date:  2016-12-28       Impact factor: 5.153

Review 6.  Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress.

Authors:  Maria Sole Chimenti; Flavia Sunzini; Laura Fiorucci; Elisabetta Botti; Giulia Lavinia Fonti; Paola Conigliaro; Paola Triggianese; Luisa Costa; Francesco Caso; Alessandro Giunta; Maria Esposito; Luca Bianchi; Roberto Santucci; Roberto Perricone
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

7.  Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms.

Authors:  Payal Rana; Michael D Aleo; Xuerong Wen; Stephen Kogut
Journal:  Acta Pharm Sin B       Date:  2021-06-07       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.